BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2160133)

  • 1. Platelet modulation of neutrophil superoxide anion production.
    Moon DG; van der Zee H; Weston LK; Gudewicz PW; Fenton JW; Kaplan JE
    Thromb Haemost; 1990 Feb; 63(1):91-6. PubMed ID: 2160133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet enhancement of O2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide.
    Ward PA; Cunningham TW; McCulloch KK; Phan SH; Powell J; Johnson KJ
    Lab Invest; 1988 Jan; 58(1):37-47. PubMed ID: 2826882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.
    Stewart AG; Harris T
    Immunology; 1993 Jan; 78(1):152-8. PubMed ID: 8382188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of platelet-derived factors that modulate functions of polymorphonuclear leukocytes].
    Sasada M; Asagoe K
    Rinsho Ketsueki; 1994 Apr; 35(4):381-5. PubMed ID: 8028184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
    Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
    J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lexipafant inhibits platelet activating factor enhanced neutrophil functions.
    Schwartz JD; Shamamian P; Grossi EA; Schwartz DS; Marcus SG; Steiner F; Jacobs CE; Tayyarah M; Eng K; Colvin SB; Galloway AC
    J Surg Res; 1997 May; 69(2):240-8. PubMed ID: 9224389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils.
    Aktan I; Dunkel B; Cunningham FM
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):209-17. PubMed ID: 23332730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of ionized cytoplasmic calcium mobilization with the photoprotein aequorin in human polymorphonuclear leukocytes activated by platelet activating factor (PAF).
    Del Maschio A; Albors M; Evangelista V; Bucchi F; Bertelé V; Cerletti C; de Gaetano G
    J Lipid Mediat; 1989; 1(1):25-36. PubMed ID: 2562430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-induced leukopenia and thrombocytopenia are attenuated by PAF antagonist WEB 2086.
    van der Zee H; Moon DG; Kaplan JE; Gudewicz PW; Fenton J
    J Lab Clin Med; 1991 Apr; 117(4):305-12. PubMed ID: 1901342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction of adenosine with leukocytes and thrombocytes].
    Becker BF; Zahler S; Seligmann C; Kupatt C; Habazettl H
    Z Kardiol; 1996; 85 Suppl 6():161-70. PubMed ID: 9064961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets and ATP prime neutrophils for enhanced O2- generation at low concentrations but inhibit O2- generation at high concentrations.
    Naum CC; Kaplan SS; Basford RE
    J Leukoc Biol; 1991 Jan; 49(1):83-9. PubMed ID: 1845813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
    Breviario F; Bertocchi F; Dejana E; Bussolino F
    J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release.
    Barnett CC; Moore EE; Partrick DA; Silliman CC
    J Surg Res; 1997 Jul; 70(2):166-70. PubMed ID: 9245567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human blood platelets, PMN leukocytes and their interactions in vitro. Responses to selective and non-selective stimuli.
    Drábiková K; Jancinová V; Nosál R; Danihelová E
    Gen Physiol Biophys; 2000 Dec; 19(4):393-404. PubMed ID: 11409842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP induces transient elevations of [Ca2+]i in human neutrophils and primes these cells for enhanced O2- generation.
    Kuhns DB; Wright DG; Nath J; Kaplan SS; Basford RE
    Lab Invest; 1988 Apr; 58(4):448-53. PubMed ID: 2833660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.